Private equity's glory days are over
Earlier this decade, the private-equity industry saw the biggest leveraged buyouts in history. But don't count on those days returning soon.
Earlier this decade, the private-equity industry saw the biggest leveraged buyouts in history. But don't count on those days returning soon, says The Economist.
One obstacle to recovery is that the industry is having trouble selling its investments. The revival in stocks has helped, but now seems to be faltering.
With investors "more focused than ever on buying healthy balance sheets", as Timothy Montfort of Jefferies & Co told Bloomberg.com, flogging debt-laden firms is tricky. It hardly helps that there are currently $4.2bn of private-equity sales in the US IPO pipeline.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Making investments has become harder too, says The Economist. Bank debt is more expensive and demand from collateralised loan obligations (CLOs), funds that eagerly bought up leveraged loans in the boom, is mostly gone.
The steep fees the industry charged "look indefensible now", while around $378bn of private-equity debt will need to be refinanced over the next four years.
The upshot is that the number of firms in the industry could shrink by 70%, according to some estimates. "Private equity is not dead. But its best days look behind it."
The big picture: outstanding value among defensives
Back in June, Citigroup noted that a basket of ten major European defensive stocks were seriously cheap on an average forward p/e of less than ten. The only time that had happened in the past 25 years was in the early 1990s recession.
Now, even although the stocks (Nstle; Vodafone; GlaxoSmithKline; Telefonica; Sanofi-Aventis; E.On; BAT; GDF Suez; Unilever and ENEL) have gained an average of 15% since June, they're still in the bargain basement, highlighting how solid stocks have been left behind in the rally.
They now trade at an average forward p/e of just 11. "There appears to be outstanding value here".
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published